167 related articles for article (PubMed ID: 19533094)
1. PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate.
Boldt J
Intensive Care Med; 2009 Aug; 35(8):1331-6. PubMed ID: 19533094
[TBL] [Abstract][Full Text] [Related]
2. Modern rapidly degradable hydroxyethyl starches: current concepts.
Boldt J
Anesth Analg; 2009 May; 108(5):1574-82. PubMed ID: 19372338
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?
Boldt J
Drug Saf; 2002; 25(12):837-46. PubMed ID: 12241125
[TBL] [Abstract][Full Text] [Related]
4. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
Suttner S; Boldt J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
[TBL] [Abstract][Full Text] [Related]
5. [Hydroxyethylstarch (HES)].
Boldt J
Wien Klin Wochenschr; 2004 Mar; 116(5-6):159-69. PubMed ID: 15088990
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
Mutter TC; Ruth CA; Dart AB
Cochrane Database Syst Rev; 2013 Jul; (7):CD007594. PubMed ID: 23881659
[TBL] [Abstract][Full Text] [Related]
7. Molecular weight and molar substitution are more important in HES-induced renal impairment than concentration after hemorrhagic and septic shock.
Simon TP; Thiele C; Schuerholz T; Fries M; Stadermann F; Haase G; Amann KU; Marx G
Minerva Anestesiol; 2015 Jun; 81(6):608-18. PubMed ID: 25296880
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation.
Blasco V; Leone M; Antonini F; Geissler A; Albanèse J; Martin C
Br J Anaesth; 2008 Apr; 100(4):504-8. PubMed ID: 18256055
[TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of the effects of administration of tetrastarch (hydroxyethyl starch 130/0.4) on plasma creatinine concentration in dogs (2010-2013): 201 dogs.
Yozova ID; Howard J; Adamik KN
J Vet Emerg Crit Care (San Antonio); 2016 Jul; 26(4):568-77. PubMed ID: 27144501
[TBL] [Abstract][Full Text] [Related]
10. An international view of hydroxyethyl starches.
Treib J; Baron JF; Grauer MT; Strauss RG
Intensive Care Med; 1999 Mar; 25(3):258-68. PubMed ID: 10229159
[TBL] [Abstract][Full Text] [Related]
11. Plasma substitutes.
Boldt J; Suttner S
Minerva Anestesiol; 2005 Dec; 71(12):741-58. PubMed ID: 16288182
[TBL] [Abstract][Full Text] [Related]
12. Controversies in the use of hydroxyethyl starch solutions in small animal emergency and critical care.
Adamik KN; Yozova ID; Regenscheit N
J Vet Emerg Crit Care (San Antonio); 2015; 25(1):20-47. PubMed ID: 25655725
[TBL] [Abstract][Full Text] [Related]
13. Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation.
von Roten I; Madjdpour C; Frascarolo P; Burmeister MA; Fisch A; Schramm S; Bombeli T; Spahn DR
Br J Anaesth; 2006 Apr; 96(4):455-63. PubMed ID: 16464978
[TBL] [Abstract][Full Text] [Related]
14. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight.
Entholzner EK; Mielke LL; Calatzis AN; Feyh J; Hipp R; Hargasser SR
Acta Anaesthesiol Scand; 2000 Oct; 44(9):1116-21. PubMed ID: 11028733
[TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
16. To dose or not to dose: that is the (starch) question ..
Kaplan LJ
Crit Care; 2010; 14(3):148. PubMed ID: 20459591
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
Bagshaw SM; Chawla LS
Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyethyl starch--can the safety problems be ignored?
Wiedermann CJ
Wien Klin Wochenschr; 2004 Sep; 116(17-18):583-94. PubMed ID: 15515874
[TBL] [Abstract][Full Text] [Related]
19. Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients.
Boldt J; Mayer J; Brosch C; Lehmann A; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):399-407. PubMed ID: 20510247
[TBL] [Abstract][Full Text] [Related]
20. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
Ehrly AM; Landgraf H
Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
